• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Randomized Phase IIa Clinical Study of an Anti-αβ Monoclonal Antibody in Idiopathic Pulmonary Fibrosis.

作者信息

Raghu Ganesh, Mouded Majd, Prasse Antje, Stebbins Christopher, Zhao Guolin, Song Guochen, Arefayene Million, Violette Shelia M, Gallagher Diana, Gibson Kevin F

机构信息

Center for Interstitial Lung Diseases University of Washington Medical Center Seattle, Washington.

Biogen, Inc. Cambridge, Massachusetts.

出版信息

Am J Respir Crit Care Med. 2022 Nov 1;206(9):1166-1168. doi: 10.1164/rccm.202205-0868LE.

DOI:10.1164/rccm.202205-0868LE
PMID:35830489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9704833/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7890/9704833/239bf09bc4e1/rccm.202205-0868LEf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7890/9704833/239bf09bc4e1/rccm.202205-0868LEf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7890/9704833/239bf09bc4e1/rccm.202205-0868LEf1.jpg

相似文献

1
Randomized Phase IIa Clinical Study of an Anti-αβ Monoclonal Antibody in Idiopathic Pulmonary Fibrosis.抗αβ单克隆抗体治疗特发性肺纤维化的随机IIa期临床研究
Am J Respir Crit Care Med. 2022 Nov 1;206(9):1166-1168. doi: 10.1164/rccm.202205-0868LE.
2
Goldilocks and the Three Trials: Clinical Trials Targeting the αβ Integrin in Idiopathic Pulmonary Fibrosis.金发姑娘与三项试验：针对特发性肺纤维化中αβ整合素的临床试验
Am J Respir Crit Care Med. 2022 Nov 1;206(9):1062-1063. doi: 10.1164/rccm.202208-1579ED.
3
Preclinical SPECT/CT imaging of αvβ6 integrins for molecular stratification of idiopathic pulmonary fibrosis.αvβ6 整联蛋白的临床前 SPECT/CT 成像用于特发性肺纤维化的分子分层。
J Nucl Med. 2013 Dec;54(12):2146-52. doi: 10.2967/jnumed.113.120592. Epub 2013 Oct 28.
4
Inhibition of the αvβ6 integrin leads to limited alteration of TGF-α-induced pulmonary fibrosis.抑制αvβ6 整合素导致 TGF-α 诱导的肺纤维化的改变有限。
Am J Physiol Lung Cell Mol Physiol. 2014 Apr 15;306(8):L726-35. doi: 10.1152/ajplung.00357.2013. Epub 2014 Feb 7.
5
Translational pharmacology of an inhaled small molecule αvβ6 integrin inhibitor for idiopathic pulmonary fibrosis.一种用于特发性肺纤维化的吸入型小分子αvβ6整合素抑制剂的转化药理学
Nat Commun. 2020 Sep 16;11(1):4659. doi: 10.1038/s41467-020-18397-6.
6
A Phase IIb Randomized Clinical Study of an Anti-αβ Monoclonal Antibody in Idiopathic Pulmonary Fibrosis.一项抗 αβ 单克隆抗体治疗特发性肺纤维化的 IIb 期随机临床试验。
Am J Respir Crit Care Med. 2022 Nov 1;206(9):1128-1139. doi: 10.1164/rccm.202112-2824OC.
7
Amplification of TGFβ Induced ITGB6 Gene Transcription May Promote Pulmonary Fibrosis.转化生长因子β诱导的整合素β6基因转录扩增可能促进肺纤维化。
PLoS One. 2016 Aug 5;11(8):e0158047. doi: 10.1371/journal.pone.0158047. eCollection 2016.
8
Inhibition of integrin alpha(v)beta6, an activator of latent transforming growth factor-beta, prevents radiation-induced lung fibrosis.抑制整合素α(v)β6（一种潜在转化生长因子-β的激活剂）可预防放射性肺纤维化。
Am J Respir Crit Care Med. 2008 Jan 1;177(1):82-90. doi: 10.1164/rccm.200706-806OC. Epub 2007 Oct 4.
9
Influenza promotes collagen deposition via αvβ6 integrin-mediated transforming growth factor β activation.流感通过αvβ6整合素介导的转化生长因子β激活促进胶原蛋白沉积。
J Biol Chem. 2014 Dec 19;289(51):35246-63. doi: 10.1074/jbc.M114.582262. Epub 2014 Oct 22.
10
αβ Integrin Positron Emission Tomography of Lung Fibrosis in Idiopathic Pulmonary Fibrosis and Long COVID-19.特发性肺纤维化和长新冠中肺纤维化的αβ整合素正电子发射断层扫描
Am J Respir Crit Care Med. 2023 Jun 15;207(12):1633-1635. doi: 10.1164/rccm.202206-1107IM.

引用本文的文献

1
Mechanosensing Pathways in the Progression of Pulmonary Fibrosis.肺纤维化进展中的机械传感通路
Curr Opin Biomed Eng. 2025 Sep;35. doi: 10.1016/j.cobme.2025.100598. Epub 2025 May 17.
2
Temporo-spatial cellular atlas of the regenerating alveolar niche in idiopathic pulmonary fibrosis.特发性肺纤维化中再生肺泡生态位的时空细胞图谱
Nat Commun. 2025 Aug 4;16(1):7150. doi: 10.1038/s41467-025-61880-1.
3
Advances in idiopathic pulmonary fibrosis diagnosis and treatment.特发性肺纤维化诊断与治疗的进展

本文引用的文献

1
A Phase IIb Randomized Clinical Study of an Anti-αβ Monoclonal Antibody in Idiopathic Pulmonary Fibrosis.一项抗 αβ 单克隆抗体治疗特发性肺纤维化的 IIb 期随机临床试验。
Am J Respir Crit Care Med. 2022 Nov 1;206(9):1128-1139. doi: 10.1164/rccm.202112-2824OC.
2
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.特发性肺纤维化诊断。美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68. doi: 10.1164/rccm.201807-1255ST.
3
BAL Cell Gene Expression Is Indicative of Outcome and Airway Basal Cell Involvement in Idiopathic Pulmonary Fibrosis.
Chin Med J Pulm Crit Care Med. 2025 Mar 7;3(1):12-21. doi: 10.1016/j.pccm.2025.02.001. eCollection 2025 Mar.
4
Mechanosignaling via Integrins: Pivotal Players in Liver Fibrosis Progression and Therapy.通过整合素的机械信号传导：肝纤维化进展和治疗中的关键因素
Cells. 2025 Feb 12;14(4):266. doi: 10.3390/cells14040266.
5
Advances and challenges in kidney fibrosis therapeutics.肾纤维化治疗的进展与挑战
Nat Rev Nephrol. 2025 May;21(5):314-329. doi: 10.1038/s41581-025-00934-5. Epub 2025 Feb 11.
6
Progressive lung fibrosis: reprogramming a genetically vulnerable bronchoalveolar epithelium.进行性肺纤维化：对具有遗传易感性的支气管肺泡上皮进行重编程。
J Clin Invest. 2025 Jan 2;135(1):e183836. doi: 10.1172/JCI183836.
7
Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial.贝索特格拉斯特治疗特发性肺纤维化患者：INTEGRIS-IPF 临床试验。
Am J Respir Crit Care Med. 2024 Aug 15;210(4):424-434. doi: 10.1164/rccm.202403-0636OC.
8
Pulmonary Fibrosis and Diabetes Mellitus: Two coins with the same face.肺纤维化与糖尿病：同一枚硬币的两面。
Arch Intern Med Res. 2024;7(1):53-70. doi: 10.26502/aimr.0165. Epub 2024 Mar 16.
9
Integrating mechanical cues with engineered platforms to explore cardiopulmonary development and disease.将机械信号与工程平台相结合以探索心肺发育与疾病。
iScience. 2023 Nov 15;26(12):108472. doi: 10.1016/j.isci.2023.108472. eCollection 2023 Dec 15.
10
PTK2-associated gene signature could predict the prognosis of IPF.PTK2 相关基因特征可预测 IPF 的预后。
Respir Res. 2023 Dec 6;24(1):304. doi: 10.1186/s12931-023-02582-4.
BAL 细胞基因表达可预测特发性肺纤维化的结局和气道基底细胞受累情况。
Am J Respir Crit Care Med. 2019 Mar 1;199(5):622-630. doi: 10.1164/rccm.201712-2551OC.
4
New insights into TGF-β/Smad signaling in tissue fibrosis.组织纤维化中 TGF-β/Smad 信号通路的新见解。
Chem Biol Interact. 2018 Aug 25;292:76-83. doi: 10.1016/j.cbi.2018.07.008. Epub 2018 Jul 11.
5
Inhibition of the αvβ6 integrin leads to limited alteration of TGF-α-induced pulmonary fibrosis.抑制αvβ6 整合素导致 TGF-α 诱导的肺纤维化的改变有限。
Am J Physiol Lung Cell Mol Physiol. 2014 Apr 15;306(8):L726-35. doi: 10.1152/ajplung.00357.2013. Epub 2014 Feb 7.
6
TGF-β activation and lung fibrosis.TGF-β 的激活与肺纤维化。
Proc Am Thorac Soc. 2012 Jul;9(3):130-6. doi: 10.1513/pats.201201-003AW.
7
Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammation.整合素α(v)β6的部分抑制可预防肺纤维化而不加重炎症。
Am J Respir Crit Care Med. 2008 Jan 1;177(1):56-65. doi: 10.1164/rccm.200706-805OC. Epub 2007 Oct 4.
8
Inhibition of integrin alpha(v)beta6, an activator of latent transforming growth factor-beta, prevents radiation-induced lung fibrosis.抑制整合素α(v)β6（一种潜在转化生长因子-β的激活剂）可预防放射性肺纤维化。
Am J Respir Crit Care Med. 2008 Jan 1;177(1):82-90. doi: 10.1164/rccm.200706-806OC. Epub 2007 Oct 4.
9
Acute exacerbations of idiopathic pulmonary fibrosis.特发性肺纤维化的急性加重
Am J Respir Crit Care Med. 2007 Oct 1;176(7):636-43. doi: 10.1164/rccm.200703-463PP. Epub 2007 Jun 21.
10
The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis.整合素αvβ6结合并激活潜伏的转化生长因子β1：一种调节肺部炎症和纤维化的机制。
Cell. 1999 Feb 5;96(3):319-28. doi: 10.1016/s0092-8674(00)80545-0.